危重肝硬化患者首周急性肾损伤未缓解预示慢性肾脏病发生
研究纳入310例危重肝硬化患者,评估尿NGAL及肾小管上皮细胞(RTEC)与第7天急性肾损伤未缓解(AKI-NR)及慢性肾脏病(CKD)的关系。第7天53%存在AKI-NR,随访136天48.3%发生CKD,RTEC、颗粒管型、NGAL及AKI-NR为CKD独立预测因子。
要点
- 危重肝硬化患者第7天AKI-NR发生率为53%,随访期间CKD发生率为48.3%。
- 尿NGAL、RTEC或颗粒管型是AKI-NR和CKD发生的独立预测因子。
- AKI-NR患者肾小管修复标志物降低、线粒体生物合成障碍,肾活检见单核巨噬细胞浸润及肾小管间质纤维化。
核心结论
- 危重肝硬化患者中近三分之二发生AKI,第7天仅一半缓解,且AKI-NR预测CKD发生。
- 较高NGAL、RTEC或颗粒管型是AKI-NR和CKD发生的独立预测因子。
- 肾小管和内皮损伤增强、修复减少、单核巨噬细胞浸润及RTEC线粒体功能障碍与AKI未缓解及肾纤维化风险相关。
研究设计与样本
- 在危重肝硬化患者中入组时及第7天检测尿NGAL和尿沉渣镜检,评估17项肾损伤、内皮损伤及修复标志物。
- 采用qRT-PCR检测RTEC线粒体生物合成相关基因,并进行死后肾活检以理解AKI未缓解机制(n=30)。
- 共纳入310例患者,年龄48.1±11.6岁,87%男性,90%酒精性。
主要发现
- 入组时36%存在RTEC,第7天53%存在AKI-NR。
- 平均随访136天(范围43-365天),150例(48.3%)发生CKD。
- 竞争风险分析显示RTEC或颗粒管型、NGAL及AKI-NR为CKD发生的独立预测因子。
- 与AKI-R相比,AKI-NR患者MCP-1更高、肾内皮损伤更重、肾小管修复标志物降低、RTEC线粒体生物合成障碍(p<0.05)。
- 肾活检显示单核巨噬细胞浸润、α-SMA升高及肾小管间质纤维化。
关键数值与推荐
- AKI-NR定义为第7天急性肾损伤未缓解。
- CKD在平均随访136天(范围43-365天)内评估,150例(48.3%)发生。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Renal tubular epithelial cells (RTECs) cause maladaptive repair and perpetuate renal fibrosis. AIM: To evaluate urinary neutrophil gelatinase-associated lipocalin (NGAL) and RTEC as risk factors for non-resolution of acute kidney injury (AKI-NR) at day seven and chronic kidney disease (CKD) in critically ill patients with cirrhosis. METHODS: We performed urinary NGAL and microscopy at enrolment and day 7 in all patients. We assessed 17 renal injury, endothelial injury and repair markers, genes for mitochondrial biogenesis by qRT-PCR in RTEC, and post-mortem renal biopsies for understanding mechanisms of AKI non-resolution (n = 30). RESULTS: We enrolled 310 patients, aged 48.1 ± 11.6 years, 87% male, 90% alcoholic. Of these, 36% had RTEC at enrolment, and 53% had AKI-NR on day 7. On mean follow-up of 136 days (range 43-365), 150 (48.3%) developed CKD. The presence of RTEC or granular casts, NGAL and AKI-NR were independent predictors of CKD development on competing risk analysis. Higher MCP-1, renal endothelial injury, decrease in tubular repair markers and failure of mitochondrial biogenesis in RTEC were seen in patients with AKI-NR compared with AKI-R (p < 0.05). Renal biopsies showed infiltration with monocyte-macrophage, increased α-SMA, and tubulointerstitial fibrosis. CONCLUSION: Almost two-thirds of critically ill patients with cirrhosis have AKI, which resolves in only one-half at day seven and predicts the development of CKD. Higher NGAL, RTEC, or granular casts were independent predictors of AKI-NR and CKD development. Enhanced tubular and endothelial injury, decreased repair, monocyte-macrophage infiltration and mitochondrial dysfunction in RTEC are associated with AKI non-resolution and risk of renal fibrosis.
引用
- Maiwall R, Pasupuleti SSR, Hidam AK, et al. Non-resolution of acute kidney injury in the first week portends the development of chronic kidney disease in critically ill patients with cirrhosis. Aliment Pharmacol Ther. 2023. PMID: 37455381. doi:10.1111/apt.17639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。